Allarity Therapeutics Inc...

0.94
0.14 (17.93%)
At close: Apr 17, 2025, 3:59 PM
0.93
-1.28%
After-hours: Apr 17, 2025, 07:57 PM EDT

Allarity Therapeutics Statistics

Share Statistics

Allarity Therapeutics has 17.01M shares outstanding. The number of shares has increased by -82.67% in one year.

Shares Outstanding 17.01M
Shares Change (YoY) -82.67%
Shares Change (QoQ) 0%
Owned by Institutions (%) 19.14%
Shares Floating 13M
Failed to Deliver (FTD) Shares 417
FTD / Avg. Volume 0.02%

Short Selling Information

The latest short interest is 1.2M, so 7.05% of the outstanding shares have been sold short.

Short Interest 1.2M
Short % of Shares Out 7.05%
Short % of Float 7.05%
Short Ratio (days to cover) 1

Valuation Ratios

The PE ratio is 0 and the forward PE ratio is -0.02. Allarity Therapeutics's PEG ratio is 0.

PE Ratio 0
Forward PE -0.02
PS Ratio 0
Forward PS 0.2
PB Ratio 0
P/FCF Ratio 0
PEG Ratio 0
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Allarity Therapeutics.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 2.06, with a Debt / Equity ratio of 0.11.

Current Ratio 2.06
Quick Ratio 2.06
Debt / Equity 0.11
Debt / EBITDA -0.05
Debt / FCF -0.08
Interest Coverage 41.72

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $0
Profits Per Employee $-4.09M
Employee Count 6
Asset Turnover 0
Inventory Turnover n/a

Taxes

Income Tax -381K
Effective Tax Rate 1.53%

Stock Price Statistics

The stock price has increased by -97.97% in the last 52 weeks. The beta is -0.07, so Allarity Therapeutics's price volatility has been lower than the market average.

Beta -0.07
52-Week Price Change -97.97%
50-Day Moving Average 0.93
200-Day Moving Average 2.25
Relative Strength Index (RSI) 54.39
Average Volume (20 Days) 2.37M

Income Statement

Revenue n/a
Gross Profit 0
Operating Income -27.24M
Net Income -24.52M
EBITDA -27.24M
EBIT -25.55M
Earnings Per Share (EPS) 0
Full Income Statement

Balance Sheet

The company has 19.53M in cash and 1.35M in debt, giving a net cash position of 18.18M.

Cash & Cash Equivalents 19.53M
Total Debt 1.35M
Net Cash 18.18M
Retained Earnings -118.97M
Total Assets 22.65M
Working Capital 11.5M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -17.35M and capital expenditures -298K, giving a free cash flow of -17.65M.

Operating Cash Flow -17.35M
Capital Expenditures -298K
Free Cash Flow -17.65M
FCF Per Share 0
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

ALLR does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

Currently there are no analyst rating for ALLR.

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Stock Forecasts

Stock Splits

The last stock split was on Sep 11, 2024. It was a backward split with a ratio of 1:30.

Last Split Date Sep 11, 2024
Split Type backward
Split Ratio 1:30

Scores

Altman Z-Score -9.66
Piotroski F-Score 3